Let’s Talk Optometry: an Evolve Medical Education Podcast

Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which inclu...

Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the ce...

Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub o...

Jessica Steen, OD, FAAO, discusses data from the Score2 clinical trial as well as four cases that highlight how patients with RVOs with macular edema require long-term treatment from a multispeciality team. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here Dr. Steen's webinar event, which includes images from the talk. Check out the cen...

In this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that recurred following orbital decompression surgery and presented with diplopia. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to...

Join Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Wan...

In this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a case study highlighting the successful use of biologic therapy in managing chronic TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics....

Kim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six other eye care providers, and was eventually successfully treated with teprotumumab. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click...

Classification of neurotrophic keratitis is moving away from the Mackie system. Drs. Nichols and Whitley highlight the Neurotrophic Keratitis Study Group classification system and explain the clinical features of each stage. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central...

Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, explain why it’s important to perform corneal sensitivity testing on patients suspected of having neurotrophic keratitis and provide tips on best practices.  This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the centra...

Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, present two cases and discuss why neurotrophic keratitis is difficult to diagnose and more prevalent than previously thought. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Wa...

Mark T. Dunbar, OD, FAAO and Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, highlight the workup recommendations for patients 50 years and older suspected of having a retinal vein occlusion (RVO) as well as a case of branch RVO. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the tal...

Mark T. Dunbar, OD, FAAO and Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, discuss the prevalence and symptoms of retinal vein occlusions (RVOs) as well as a case of branch RVO. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar serie...

Kelly K. Nichols, OD, MPH, PhD, FAAO, and Walter O. Whitley, OD, MBA, FAAO, discuss how meibomian gland dysfunction interacts with dry eye disease (DED) and summarize the latest clinical and real-world data on new and emerging treatments.  This content was captured during a synchronous in-person and virtual symposium. Polling took place during the symposium. This activity is supported by an unrest...

Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies as well as the pipeline. Drs. Periman and Brujic also present cases. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant...

Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which...

Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Steen discusses recent comparison studies. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar,...

Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Brujic highlights dry eye disease’s prevalence, risk factors, and diagnostic tools. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point....

Steven Ferrucci, OD, FAAO, FORS, highlights two patients who present with multiple risk factors for retinal vein occlusions. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view Dr. Ferrucci's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical E...

Carolyn E. Majcher, OD, FAAO, FORS, discusses patients with retinal vein occlusions that mimicked other retinal pathologies. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view Dr. Majcher's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Ed...

Carolyn E. Majcher, OD, FAAO, FORS, presents cases that emphasize the importance of systemic evaluation in unusual retinal vein occlusion presentations as well as the utility of multimodal imaging such as OCT angiography. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view Dr. Majcher's webinar event, which includes images from th...

Which interventional strategies may lead to positive outcomes for patients with geographic atrophy (GA)? Join Christina Y. Weng, MD, MBA, as she contextualizes select portions of a roundtable moderated by Roger A. Goldberg, MD, MBA. The roundtable included two leading optometrists and two leading retina specialists discussing how complement modulation may be the key to unlocking successful treatme...

How do leading optometrists and ophthalmologists navigate management of geographic atrophy (GA)? Christina Y. Weng, MD, MBA, guides you as you listen in on a roundtable conversation chaired by Roger A. Goldberg, MD, MBA. During the roundtable, Dr. Goldberg asks a pair of optometrists and a pair of retina specialists which anatomic markers they emphasize during examination of GA patients, explore t...

This podcast, which took place prior to the approval of pegcetacoplan, features Drs. Sadda, Modi, and Baumal discussing the newly approved and potential therapies as well as risk factors that drive the disease, imaging modalities that are best suited for GA evaluation, and the type of lesion patterns that place patients at high risk for progression. This activity is supported by an unrestricted me...